MetLife Investment Management’s Mandiant, Inc. Common Stock MNDT Stock Holding History

MetLife Investment Management’s Portfolio MNDT Stock Details MNDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,837	Closed	-$106K	–	2871
2022 Q2	$106K	Sell	4,837 -2,918	-38%	-$64.1K	﹤0.01%	2689
2022 Q1	$173K	Buy	+7,755	New	+$143K	﹤0.01%	2445
2019 Q2	–	Sell	-265	Closed	-$4.45K	–	2628
2019 Q1	$4.45K	Buy	265 +1	+0.4%	+$17	﹤0.01%	2491
2018 Q4	$4.28K	Buy	264 +1	+0.4%	+$18	﹤0.01%	2475
2018 Q3	$4.47K	Buy	+263	New	+$4.21K	﹤0.01%	2537

Other funds holding MNDT

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MetLife Investment Management's MNDT Position: Q3 2022 in Review

MetLife Investment Management sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 4,837 shares — an estimated $106K sold.

MetLife Investment Management first reported a position in MNDT in Q3 2018 and held it in 5 quarters. The position peaked at $173K in Q1 2022. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.

MetLife Investment Management reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
MetLife Investment Management sold 4,837 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $106K.
MetLife Investment Management first reported a position in Mandiant, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
MetLife Investment Management's Mandiant, Inc. Common Stock position peaked at $173K in Q1 2022.
3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.